@article{TAU15302,
author = {Michele Scialpi and Valeria Rondoni and Maria Cristina Aisa and Eugenio Martorana and Alfredo D’Andrea and Corrado Maria Malaspina and Agostino Orlandi and Giorgio Galassi and Emanuele Orlandi and Pietro Scialpi and Michele Dragone and Diego Palladino and Annalisa Simeone and Michele Amenta and Giampaolo Bianchi},
title = {Is contrast enhancement needed for diagnostic prostate MRI?},
journal = {Translational Andrology and Urology},
volume = {6},
number = {3},
year = {2017},
keywords = {},
abstract = {Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) provides clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) [T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI)] of prostate. However, DCE-MRI seems to show a limited contribution in prostate cancer (PCa) detection and management. In our experience, DCE-MRI, did not show significant change in diagnostic performance in addition to DWI and T2WI [biparametric MRI (bpMRI)] which represent the predominant sequences to detect suspected lesions in peripheral and transitional zone (TZ). In this article we reviewed the role of DCE-MRI also indicating the potential contribute of bpMRI approach (T2WI and DWI) and lesion volume evaluation in the diagnosis and management of suspected PCa.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/15302}
}